By Patrick Crutcher
The recent trading activity in shares of Depomed Inc.(DEPO) has triggered a trade alert. Institutions and funds have been accumulating shares of DEPO the past few weeks and it appears to be ready for the next leg up. January has fewer FDA decisions, so we expect DEPO to gain a lot of attention as biotech investors look for favorable investment opportunities.
Read the complete article here.
Happy trading,
Curt
More on this topic
(What's this?)
Puts Purchased on Depomed, Inc. (DEPO)
(Benzinga, 10/19/10)
Napodano: Depomed Plans Serada NDA
(, 4/24/12)
NASDAQ Stocks Hitting 52-Week Highs (DEPO, AGAM, AAPL, ISTA)
(Benzinga, 10/18/10)
Napodano: Modeling Shows Depomed Undervalued
(, 3/11/12)

![[del.icio.us]](http://pennystockdd.com/wp-content/plugins/bookmarkify/delicious.png)
![[Digg]](http://pennystockdd.com/wp-content/plugins/bookmarkify/digg.png)
![[Faves]](http://pennystockdd.com/wp-content/plugins/bookmarkify/faves.png)
![[LinkedIn]](http://pennystockdd.com/wp-content/plugins/bookmarkify/linkedin.png)
![[Reddit]](http://pennystockdd.com/wp-content/plugins/bookmarkify/reddit.png)
![[StumbleUpon]](http://pennystockdd.com/wp-content/plugins/bookmarkify/stumbleupon.png)
![[Technorati]](http://pennystockdd.com/wp-content/plugins/bookmarkify/technorati.png)




